Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Cellectar Biosciences, Inc. (CLRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 77.33 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-04
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 75.00K shares, a 25.00% decline year-over-year.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 63.00K shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 746.50K shares, a 1096.31% increase year-over-year.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 732.50K shares, a 163.63% increase year-over-year.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 77.33K shares, a 24.27% decline from fiscal 2024.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 102.12K shares, a 93.68% decline from fiscal 2023.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.62M shares, a 267.29% increase from fiscal 2022.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 440.25K shares, a 24.45% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 77.33K shares 10-K · filed 2026-03-04 | ||||||||||
| 2024-12-31 | 102.12K shares 10-K · filed 2026-03-04 | 3.06M shares 10-K · filed 2025-03-13 | |||||||||
| 2023-12-31 | 75.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 138.00K shares derived: sum of 2 quarters · filed 2025-03-13 | 884.50K shares derived: sum of 3 quarters · filed 2025-03-13 | 1.62M shares 10-K · filed 2025-03-13 | |||||||
| 2023-09-30 | 63.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 809.50K shares derived: sum of 2 quarters · filed 2023-11-13 | 1.54M shares 10-Q · filed 2023-11-13 | 1.64M shares derived: sum of 4 quarters · filed 2024-10-29 | |||||||
| 2023-06-30 | 746.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 1.48M shares 10-Q · filed 2023-08-14 | 1.58M shares derived: sum of 3 quarters · filed 2024-10-29 | 1.58M shares derived: sum of 4 quarters · filed 2024-10-29 | |||||||
| 2023-03-31 | 732.50K shares 10-Q · filed 2023-05-04 | 832.50K shares derived: sum of 2 quarters · filed 2024-10-29 | 832.50K shares derived: sum of 3 quarters · filed 2024-10-29 | 894.90K shares derived: sum of 4 quarters · filed 2024-10-29 | |||||||
| 2022-12-31 | 100.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-10-29 | 100.00K shares derived: sum of 2 quarters · filed 2024-10-29 | 162.40K shares derived: sum of 3 quarters · filed 2024-10-29 | 440.25K shares 10-K/A · filed 2024-10-29 | |||||||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 340.25K shares 10-Q · filed 2022-11-03 | 340.25K shares 10-Q · filed 2023-11-13 | -2.84M shares derived: sum of 4 quarters · filed 2023-11-13 | |||||||
| 2022-06-30 | 62.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 340.25K shares 10-Q · filed 2023-08-14 | -2.84M shares derived: sum of 3 quarters · filed 2023-08-14 | 342.25K shares derived: sum of 4 quarters · filed 2023-08-14 | |||||||
| 2022-03-31 | 277.85K shares 10-Q · filed 2023-05-04 | 2.78M shares 10-Q · filed 2022-05-10 | -2.91M shares derived: sum of 2 quarters · filed 2023-05-04 | 279.85K shares derived: sum of 3 quarters · filed 2023-05-04 | 423.10K shares derived: sum of 4 quarters · filed 2023-05-04 | ||||||
| 2021-12-31 | -3.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 2.00K shares derived: sum of 2 quarters · filed 2023-03-09 | 145.25K shares derived: sum of 3 quarters · filed 2023-03-09 | 353.75K shares 10-K · filed 2023-03-09 | 3.54M shares 10-K · filed 2022-03-21 | ||||||
| 2021-09-30 | 3.19M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 353.75K shares 10-Q · filed 2022-11-03 | 3.54M shares 10-Q · filed 2021-11-08 | 3.54M shares derived: sum of 4 quarters · filed 2022-08-05 | |||||||
| 2021-06-30 | 143.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | 351.75K shares 10-Q · filed 2022-08-05 | 3.52M shares 10-Q · filed 2021-08-09 | 351.75K shares derived: sum of 3 quarters · filed 2022-08-05 | 451.75K shares derived: sum of 4 quarters · filed 2022-08-05 | ||||||
| 2021-03-31 | 208.50K shares 10-Q · filed 2022-05-10 | 208.50K shares derived: sum of 2 quarters · filed 2022-05-10 | 308.50K shares derived: sum of 3 quarters · filed 2022-05-10 | 588.50K shares derived: sum of 4 quarters · filed 2022-05-10 | |||||||
| 2021-03-04 | 281.00K shares 10-K · filed 2023-03-09 | 2.81M shares 10-Q · filed 2021-05-10 | |||||||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | 100.00K shares derived: sum of 2 quarters · filed 2022-03-21 | 380.00K shares derived: sum of 3 quarters · filed 2022-03-21 | 653.75K shares 10-K · filed 2022-03-21 | |||||||
| 2020-09-30 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 380.00K shares derived: sum of 2 quarters · filed 2021-11-08 | 653.75K shares 10-Q · filed 2021-11-08 | 653.75K shares derived: sum of 4 quarters · filed 2021-11-08 | |||||||
| 2020-06-30 | 280.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 553.75K shares 10-Q · filed 2021-08-09 | 553.75K shares derived: sum of 3 quarters · filed 2021-08-09 | 643.75K shares derived: sum of 4 quarters · filed 2021-08-09 | |||||||
| 2020-03-31 | 273.75K shares 10-Q · filed 2021-05-10 | 273.75K shares derived: sum of 2 quarters · filed 2021-05-10 | 363.75K shares derived: sum of 3 quarters · filed 2021-05-10 | ||||||||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | 90.00K shares derived: sum of 2 quarters · filed 2021-03-02 | 411.93K shares 10-K · filed 2021-03-02 | ||||||||
| 2019-09-30 | 90.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 411.93K shares 10-Q · filed 2020-11-09 | |||||||||
| 2019-06-30 | 321.93K shares 10-Q · filed 2020-08-10 | ||||||||||
| 2019-01-17 | 118.75K shares 10-K · filed 2021-03-02 | 118.75K shares 10-Q · filed 2019-11-12 | |||||||||
| 2018-12-31 | 176.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 176.13K shares derived: sum of 2 quarters · filed 2020-03-09 | 184.13K shares 10-K · filed 2020-03-09 | ||||||||
| 2018-10-12 | 167.43K shares 10-K · filed 2021-03-02 | 167.43K shares 10-Q · filed 2019-11-12 | |||||||||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 8.00K shares 10-Q · filed 2019-11-12 | |||||||||
| 2018-06-30 | 8.00K shares 10-Q · filed 2019-08-12 | ||||||||||
| 2016-09-30 | 142.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 475.30K shares 10-Q · filed 2016-11-10 | |||||||||
| 2016-06-30 | 332.80K shares 10-Q · filed 2016-08-11 | ||||||||||
| 2015-09-30 | -5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -96.81K shares derived: sum of 2 quarters · filed 2015-11-12 | 45.00K shares 10-Q · filed 2015-11-12 | 45.00K shares derived: sum of 4 quarters · filed 2015-11-12 | |||||||
| 2015-06-30 | -91.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 50.00K shares 10-Q · filed 2015-08-12 | 50.00K shares derived: sum of 3 quarters · filed 2015-08-12 | 50.00K shares derived: sum of 4 quarters · filed 2015-08-12 | |||||||
| 2015-03-31 | 141.81K shares 10-Q · filed 2015-05-20 | 141.81K shares derived: sum of 2 quarters · filed 2015-05-20 | 141.81K shares derived: sum of 3 quarters · filed 2015-05-20 | -1.41M shares derived: sum of 4 quarters · filed 2015-05-20 | |||||||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | 0.00 shares derived: sum of 2 quarters · filed 2015-05-20 | -1.55M shares derived: sum of 3 quarters · filed 2015-05-20 | 81.81K shares 10-K · filed 2015-05-20 | |||||||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | -1.55M shares derived: sum of 2 quarters · filed 2015-05-20 | 81.81K shares 10-Q · filed 2015-05-20 | ||||||||
| 2014-06-30 | -1.55M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | 81.81K shares 10-Q · filed 2014-08-04 | |||||||||
| 2014-03-31 | 1.64M shares 10-Q · filed 2014-05-14 | ||||||||||
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |